NCT02178488

Efficacy Study of Vitamin D Supplementation to Meticillin Resistant Staphylococcus Aureus (MRSA) Carriers

Vitamin D Supplementation to Persistent Carriers of MRSA - A Double Blind, Randomised Controlled Trial

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Peter Bergman · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to treat persistent MRSA carriers with vitamin D supplementation during a 12 month to see if the number of MRSA positive patients can be reduced.

Conditions

• Methicillin Resistant Staphylococcus Aureus
• Vitamin D3 Deficiency

Interventions

Type	Name	Description
DRUG	Cholecalciferol	Cholecalciferol 4000 IU/day for 12 months
OTHER	Placebo	Placebo (mimic of cholecalciferol) in the same amount and same time frame as Cholecalciferol for 12 months

Timeline

• Start date: 2014-12-01
• Primary completion: 2017-12-01
• Completion: 2017-12-01
• First posted: 2014-06-30
• Last updated: 2018-01-23

Locations

2 sites across 1 country: Sweden